Table 2.
Conditioning regimen | Autologous n. | Allogeneic n. |
---|---|---|
Melphalan-100 | 12 | - |
Melphalan-140 | 2 | - |
Melphalan-200 | 7 | - |
BEAM | 5 | 3 |
FEAM | 1 | - |
Melphalan/mitoxantrone | 1 | 1 |
Busulfan/cyclophosphamide | - | 9 |
Fludarabine/TBl | - | 5 |
Cyclophosphamide/TBl/ATG | - | 3 |
Cyclophosphamide/thiotepa/TBI | - | 1 |
Thiotepa/fludarabine/melphalan | - | 2 |
Busulfan/cyclophosphamide/melphalan | - | 8 |
BEAM, association of carmustine, etoposide, cytosine arabinoside, melphalan; FEAM, association of fotemustine, etoposide, cytosine arabinoside, melphalan; TBI, total body irradiation; ATG, anti-thymocyte globulin.